BeOne Medicines has appointed Kandeepan Ganeshalingam as Vice-President, Head of Medical Affairs, Europe.
Leading the Medical Affairs function, Ganeshalingam will strengthen scientific leadership, evidence generation and engagement with the global oncology community. He will also be part of the European Leadership and Europe Senior Management Teams.
Ganeshalingam has more than 25 years’ experience spanning clinical medicine, oncology drug development and medical affairs. He joins the company at a pivotal stage in its evolution, as the company continues to advance oncology innovation and expand its presence in Europe.
Most recently, Ganeshalingam was responsible for Oncology Medical across Pfizer’s International Markets, including China and Japan. Before joining Pfizer, he served as Vice President, Head of International Medical Affairs at Seagen where he led medical affairs activities across international markets for the company’s oncology portfolio.
He has also held senior leadership roles at MSD, Roche and CSL Vifor, contributing to the clinical development, safety risk management, medical strategy, regulatory advancement and market access of innovative medicines across oncology, haematology and immunology. He is passionate about fostering strong collaboration between European & global policymakers, patients, healthcare providers, academic institutions and the pharmaceutical industry to deliver on the promise of equitable, innovative cancer care.
Ganeshalingam is a member of several professional societies, including the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO).